| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB10721-SP | |||
| Carrier Free | FAB10721V-100UG | |||
| Carrier Free | FAB10721U-100UG | |||
| Carrier Free | FAB10721T-100UG | |||
| Carrier Free | FAB10721S-100UG | |||
| Carrier Free | FAB10721R-100UG | |||
| Carrier Free | FAB10721N-100UG | |||
| Carrier Free | FAB10721G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1072-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1072-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-91149-25ul | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| HRP | NBP2-79369-5Plates | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06442-100ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89986-50ul | |||
![N/A Siglec-5/Siglec-14 [Biotin]](http://images.novusbio.com/fullsize2/DATA_Siglec5_Siglec14_DY1072_ELISA_1565.jpg "N/A Siglec-5/Siglec-14 [Biotin]")
![Immunohistochemistry-Paraffin: Siglec-5/CD170 Antibody [NBP1-91149] - Staining of human stomach shows no cytoplasmic positivity in glandular cells as expected.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-Immunohistochemistry-Paraffin-NBP1-91149-img0008.jpg "Immunohistochemistry-Paraffin: Siglec-5/CD170 Antibody [NBP1-91149] - Staining of human stomach shows no cytoplasmic positivity in glandular cells as expected.")
![Immunohistochemistry-Paraffin: Siglec-5/CD170 Antibody [NBP1-91149] - Staining of human bone marrow shows strong cytoplasm granular positivity in hematopoietic cells.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-Immunohistochemistry-Paraffin-NBP1-91149-img0006.jpg)
![Immunohistochemistry-Paraffin: Siglec-5/CD170 Antibody [NBP1-91149] - Staining of human smooth muscle shows weak cytoplasmic positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-Immunohistochemistry-Paraffin-NBP1-91149-img0007.jpg)
![Immunohistochemistry-Paraffin: Siglec-5/CD170 Antibody [NBP1-91149] - Staining of human tonsil shows moderate cytoplasm granular positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-Immunohistochemistry-Paraffin-NBP1-91149-img0009.jpg)
![Flow Cytometry: Siglec-5/CD170 Antibody (1A5) [NBP3-09154] - Surface staining of human peripheral blood cells using anti-CD170 (1A5) purified, GAM-APC.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-1A5-Flow-Cytometry-NBP3-09154-img0001.jpg "Flow Cytometry: Siglec-5/CD170 Antibody (1A5) [NBP3-09154] - Surface staining of human peripheral blood cells using anti-CD170 (1A5) purified, GAM-APC.")
![Western Blot: SIGLEC5 Overexpression Lysate (Adult Normal) [NBL1-15960] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for SIGLEC5.](http://images.novusbio.com/fullsize/SIGLEC5-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-15960-img0002.jpg "Western Blot: SIGLEC5 Overexpression Lysate (Adult Normal) [NBL1-15960] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for SIGLEC5.")
![Sandwich ELISA: Siglec-5/CD170 Antibody Pair [HRP] [NBP2-79369] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-Pair-[HRP]-Sandwich-ELISA-NBP2-79369-img0001.jpg "Sandwich ELISA: Siglec-5/CD170 Antibody Pair [HRP] [NBP2-79369] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.")
![Flow Cytometry: Siglec-5/CD170 Antibody (07) [NBP3-06442] - Flow cytometric analysis of Human SIGLEC5(CD170) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SIGLEC5(CD170), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-07-Flow-Cytometry-NBP3-06442-img0001.jpg "Flow Cytometry: Siglec-5/CD170 Antibody (07) [NBP3-06442] - Flow cytometric analysis of Human SIGLEC5(CD170) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SIGLEC5(CD170), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.")
![Flow Cytometry: Siglec-5/CD170 Antibody (110) [NBP2-89986] - Analysis of Human SIGLEC5(CD170) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SIGLEC5(CD170), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.](http://images.novusbio.com/fullsize/Siglec-5-CD170-Antibody-110-Flow-Cytometry-NBP2-89986-img0001.jpg "Flow Cytometry: Siglec-5/CD170 Antibody (110) [NBP2-89986] - Analysis of Human SIGLEC5(CD170) expression on human whole blood granulocytes. Cells were stained with purified anti-Human SIGLEC5(CD170), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.")